Presentation is loading. Please wait.

Presentation is loading. Please wait.

Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin β-subunit and pituitary gonadal hormones  Daphne.

Published byFrieda Ursler Modified over 5 years ago

Similar presentations

Presentation on theme: "Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin β-subunit and pituitary gonadal hormones  Daphne."— Presentation transcript:

1 Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin β-subunit and pituitary gonadal hormones  Daphne de Bruin, M.D., Igle J. de Jong, M.D., Ph.D., Eugène G.J.M. Arts, Ph.D., Janine Nuver, M.D., Ph.D., Robin P.F. Dullaart, M.D., Ph.D., Willem J. Sluiter, Ph.D., Harald J. Hoekstra, M.D., Ph.D., Dirk T. Sleijfer, M.D., Ph.D., Jourik A. Gietema, M.D., Ph.D.  Fertility and Sterility  Volume 91, Issue 6, Pages (June 2009) DOI: /j.fertnstert Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Semen quality in patients with normal and elevated levels of serum β-hCG. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin β-subunit and pituitary gonadal hormones  Daphne."

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M

Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M
Male infertility: a biomarker of individual and familial cancer risk

Male infertility: a biomarker of individual and familial cancer risk
Male contraception Fertility and Sterility

Male contraception Fertility and Sterility
Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration  Jean-noêl Hugues,

Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration  Jean-noêl Hugues,
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc. 

Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc. 
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 

Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor.
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for.

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for.
Michael M. Alper, M.D.  Fertility and Sterility 

Michael M. Alper, M.D.  Fertility and Sterility 
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Elena Moretti, Ph. D. , Giulia Collodel, Ph. D

Elena Moretti, Ph. D. , Giulia Collodel, Ph. D
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Boback M. Berookhim, M. D. , M. B. A. , Gianpiero D. Palermo, M. D

Boback M. Berookhim, M. D. , M. B. A. , Gianpiero D. Palermo, M. D
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
Medical treatment of ectopic pregnancy: a committee opinion

Medical treatment of ectopic pregnancy: a committee opinion
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.
Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters  Mary K. Samplaski, M.D., Yasir.

Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters  Mary K. Samplaski, M.D., Yasir.

Similar presentations

Ads by Google